Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Adenosine receptor A2b | ||
Ligand | BDBM561414 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Adenosine A2B Receptor Cyclic AMP GS Assay | ||
EC50 | <10±n/a nM | ||
Citation | Huang, T; Wang, X Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors US Patent US11390624 Publication Date 7/19/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Adenosine receptor A2b | |||
Name: | Adenosine receptor A2b | ||
Synonyms: | AA2BR_HUMAN | ADENOSINE A2B | ADORA2B | Adenosine receptor A2B (A2B) | Adenosine receptors A2b | Adenosine receptors; A2a & A2b | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 36341.22 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 332 | ||
Sequence: |
| ||
BDBM561414 | |||
n/a | |||
Name | BDBM561414 | ||
Synonyms: | 3-(4-amino-7-(4-methyloxazol-5-yl)-2-((6-methylpyridin-2-yl)methyl)-2H-[1,2,3]triazolo[4,5-c]pyridin-6-yl)benzonitrile | US11390624, Example 29 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H18N8O | ||
Mol. Mass. | 422.442 | ||
SMILES | Cc1ncoc1-c1c(nc(N)c2nn(Cc3cccc(C)n3)nc12)-c1cccc(c1)C#N |(1.78,2.32,;.32,2.8,;-.16,4.26,;-1.7,4.26,;-2.18,2.8,;-.93,1.9,;-.93,.36,;-2.26,-.41,;-2.26,-1.95,;-.93,-2.72,;-.93,-4.26,;.4,-1.95,;1.87,-2.43,;2.77,-1.18,;4.31,-1.18,;5.08,.15,;4.31,1.48,;5.08,2.82,;6.62,2.82,;7.39,1.48,;8.93,1.48,;6.62,.15,;1.87,.06,;.4,-.41,;-3.6,.36,;-3.6,1.9,;-4.93,2.67,;-6.27,1.9,;-6.27,.36,;-4.93,-.41,;-7.6,-.41,;-8.93,-1.18,)| | ||
Structure |